RFK Jr.'s 'Make America Healthy Again' agenda focuses on overhauling health care and food to combat chronic disease ...

On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...

Measles cases rose 20% worldwide in 2023 compared to the previous year, and vaccination rates still haven't recovered to ...

In choosing Thune, Republicans went with an establishment candidate with close ties to the outgoing and long-time Senate ...

Today's health news includes understanding Plan B's efficacy for people with higher BMIs, disparities in infant mortality, ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...